Cloning of the gamma chain of the human IL-2 receptor.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Science

• Publication date

  1992-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1631559PMID 1631559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

  1991cited by this paper
• Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax

  1991cited by this paper
• A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.

  1991cited by this paper
• Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors.

  1991cited by this paper
• SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

  1991cited by this paper
• An associated molecule, p64, with high-affinity interleukin 2 receptor.

  1990cited by this paper
• Partial agonist/antagonist mouse interleukin‐2 proteins indicate that a third component of the receptor complex functions in signal transduction.

  1990cited by this paper
• Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor.

  1990cited by this paper
• Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL- 2 binding

  1990cited by this paper
• Characterization of the heterodimeric complex of human IL-2 receptor alpha.beta chains reconstituted in a mouse fibroblast cell line, L929.

  1990cited by this paper
• Structural design and molecular evolution of a cytokine receptor superfamily.

  1990cited by this paper
• The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms.

  1990cited by this paper
• Molecular cloning and expression of the murine interleukin‐5 receptor.

  1990cited by this paper
• Molecular cloning and expression of an IL-6 signal transducer, gp130.

  1990cited by this paper
• Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family.

  1990cited by this paper
• Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor

  1989cited by this paper
• Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.

  1989cited by this paper
• Expression cloning of a receptor for human granulocyte‐macrophage colony‐stimulating factor.

  1989cited by this paper
• A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.

  1989cited by this paper
• The scanning model for translation: an update

  1989cited by this paper
• IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody.

  1989cited by this paper
• SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat

  1988cited by this paper
• Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.

  1988cited by this paper
• Interleukin-2: inception, impact, and implications.

  1988cited by this paper
• Characterization of interleukin 2-stimulated phosphorylation of 67 and 63 kDa proteins in human T-cells.

  1987cited by this paper
• Stimulation of oligodendroglial proliferation and maturation by interleukin-2

  1986cited by this paper
• High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells

  1986cited by this paper
• Distinct Reactivities of Four Monoclonal Antibodies with Human Interleukin 2 Receptor

  1985cited by this paper
• Disease research: Tropics still a low priority

  1985cited by this paper
• Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells

  1985cited by this paper
• Expression of interleukin 2 receptors on activated human B cells

  1984cited by this paper
• Response of resting human peripheral blood natural killer cells to interleukin 2

  1984cited by this paper
• Molecular cloning of cDNA encoding human interleukin-2 receptor

  1984cited by this paper
• Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

  1984cited by this paper
• Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

  1978cited by this paper

• Selective expansion of TCF7-expressing tumor-reactive T cell subpopulations during ovarian tumor-infiltrating T cell production ex vivo

  2025cites this paper
• Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella

  2025cites this paper
• Targeting γc family cytokines with biologics: current status and future prospects

  2025cites this paper
• The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases

  2025cites this paper
• Interleukin-2 and Its Receptors: Implications and Therapeutic Prospects in Immune-Mediated Disorders of Central Nervous System.

  2025cites this paper
• Mathematical model for IL-2-based cancer immunotherapy.

  2024cites this paper
• Immune deficiency phenotypes of Il2rg, Rag2 or Il2rg/Rag2 double knockout rats; establishment of human leukemia xenograft models

  2024cites this paper
• Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy

  2023cites this paper
• Cytokine signaling in chimeric antigen receptor T-cell therapy

  2023cites this paper
• Low-dose IL-2 therapy in autoimmune diseases: An update review

  2023cites this paper
• Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies

  2023cites this paper
• Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer

  2023cites this paper
• The application of Interleukin-2 family cytokines in tumor immunotherapy research

  2023cites this paper
• The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024

  2023cites this paper
• Structural basis of γ-chain family receptor sharing at the membrane level

  2023cites this paper
• Expression of Interleukin-2 receptor subunit gamma (IL-2Rγ) and its binding with IL-2 induced activation of CD4 T lymphocytes in flounder (Paralichthys olivaceus).

  2022cites this paper
• Gene therapy for inborn errors of immunity: past, present and future

  2022cites this paper
• IL-2-based approaches to Treg enhancement

  2022cites this paper
• Interleukin-2 superkines by computational design

  2022cites this paper
• Engineering interferons and interleukins for cancer immunotherapy.

  2022cites this paper
• Novel IL2RG Gene Mutation in One of Dizygotic Twins Causing Profound Changes of Receptor Structure

  2022cites this paper
• Interleukin-21 in Viral Infections

  2021cites this paper
• Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist

  2021cites this paper
• Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

  2021cites this paper
• IL-15 and IL-15Rα: Something old, something new, and something blue

  2021cites this paper
• Severe Combined Immunodeficiency

  2021cites this paper
• Implications of a ‘Third Signal’ in NK Cells

  2021influential citation
• Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy

  2020cites this paper
• Dynamic Roles for IL-2–STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations

  2020cites this paper
• Role of interleukin‐15 in cardiovascular diseases

  2020cites this paper
• ReviewImmunomodulatory Effects of IL-

  2020cites this paper
• Severe combined immunodeficiency pig as an emerging animal model for human diseases and regenerative medicines

  2019cites this paper
• Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance

  2019cites this paper
• The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications.

  2019cites this paper
• CD4 regulatory T cells: their requirement for CD80 and CD86 costimulation and their role in autoimmune hepatitis

  2019cites this paper
• The tertiary structure of &ggr;c cytokines dictates receptor sharing

  2019cites this paper
• The cytokine network involved in the host immune response to periodontitis

  2019cites this paper
• Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis

  2019cites this paper
• PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.

  2019cites this paper
• The IL‐2RG R328X nonsense mutation allows partial STAT‐5 phosphorylation and defines a critical region involved in the leaky‐SCID phenotype

  2019cites this paper
• Structural Basis for Signaling Through Shared Common γ Chain Cytokines.

  2019cites this paper
• Characterisation of chicken OX40 and OX40L

  2018cites this paper
• Isoproterenol-induced beta-2 adrenergic receptor activation negatively regulates interleukin-2 signaling.

  2018cites this paper
• Biology and regulation of IL-2: from molecular mechanisms to human therapy

  2018cites this paper
• Arginine methylation controls the strength of γc-family cytokine signaling in T cell maintenance

  2018cites this paper
• Oscillatory IL-2 stimulus reveals pertinent signaling timescales of T cell responsiveness

  2018cites this paper
• Human IL-2 receptor β mutations associated with defects in immunity and peripheral tolerance

  2018cites this paper
• Signaling and Function of Interleukin-2 in T Lymphocytes.

  2018cites this paper
• The Common Cytokine Receptor γ Chain Family of Cytokines.

  2018cites this paper
• Early‐onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms

  2018cites this paper
• Biology of IL‐2 and its therapeutic modulation: Mechanisms and strategies

  2018cites this paper
• United States Patent Tagaya

  2017cites this paper
• Severe combined immunodeficiency: From its discovery to the perspective.

  2017cites this paper
• High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy

  2017cites this paper
• Local IL-15-immunotherapy to treat melanoma

  2017cites this paper
• Tethering IL2 to Its Receptor IL2Rβ Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells.

  2017cites this paper
• Developmental and Functional Control of Natural Killer Cells by Cytokines

  2017cites this paper
• A Role for Glycosylphosphatidylinositol Anchored Proteins in T Lymphocyte Homeostasis

  2017cites this paper
• MECHANISMS OF THYMIC TOXICITY INDUCED BY ENVIRONMENTALLY RELEVANT CONCENTRATIONS OF ARSENIC

  2017cites this paper
• Tumor-related interleukins: old validated targets for new anti-cancer drug development

  2017cites this paper
• Characterisation of CD4+ T cell help in CD8+ T cell priming

  2017cites this paper
• The potential and promise of IL-15 in immuno-oncogenic therapies.

  2017cites this paper
• Induction and Maintenance Immunosuppression in Intestinal Transplantation

  2017cites this paper
• Clarifying the Confusion between Cytokine and Fc Receptor "Common Gamma Chain".

  2016cites this paper
• Isolation and culture of T cell clones for adoptive immunotherapy and epitope discovery

  2016cites this paper
• Primary Immunodeficiency Diseases - ReadingSample

  2016cites this paper
• Why do children with severe combined immunodeficiency get warts? The role of the common γ-chain in skin immunity

  2016cites this paper
• γ c Family Cytokines: Role in Immune Cell Development and Function

  2016cites this paper
• IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation

  2016cites this paper
• Current status of ex vivo gene therapy for hematological disorders: a review of clinical trials in Japan around the world

  2016cites this paper
• Combined T Cell and B Cell Deficiency – SCID Forms: T−B+

  2016cites this paper
• Orchestration of T Cell Development by Common γ Chain Cytokines

  2016cites this paper
• Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs

  2016cites this paper
• Generation of a Nonhuman Primate Model of Severe Combined Immunodeficiency Using Highly Efficient Genome Editing.

  2016cites this paper
• Common gamma chain cytokines in combinatorial immune strategies against cancer.

  2016cites this paper
• A REVIEW ON STRUCTURE, FUNCTION AND IMMUNOTHERAPY OF INTERLEUKIN-2 AND ITS RECEPTOR

  2015cites this paper
• Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules*

  2015cites this paper
• CD25+Bcl6low T follicular helper cells provide help to maturing B cells in germinal centers of human tonsil

  2015cites this paper
• IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy

  2015cites this paper
• Primary Neurolymphomatosis of the Lower Cranial Nerves Presenting as Dysphagia and Hoarseness: A Case Report

  2014cites this paper
• Severe Combined Immunodeficiency as Diseases of Defective Cytokine Signaling

  2014cites this paper
• The γ c Family of Cytokines: A Pleiotropic Family That Controls Proliferation, Survival, and Differentiation

  2014cites this paper
• Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma

  2014cites this paper
• The IL-2 cytokine family in cancer immunotherapy.

  2014cites this paper
• Th1 cytokine-based immunotherapy for cancer.

  2014cites this paper
• Pathogenic role of IL-15 in non-alcoholic fatty liver disease

  2014cites this paper
• Immune Dysregulation Leading to Chronic Autoimmunity

  2014cites this paper
• IL2Rbeta T450 phosphorylation is a positive regulator for receptor complex stability and activation of signaling molecules

  2014cites this paper
• How do Th17 cells mediate autoimmune inflammation in the central nervous system?

  2014cites this paper
• Severe Combined Immunodeficiencies

  2014cites this paper
• Interleukin 2 in cancer therapy.

  2013cites this paper
• Interleukin-2 Receptor Expression in Canine Cutaneous Mast Cell Tumors

  2013cites this paper
• Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma.

  2013cites this paper
• Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

  2013cites this paper
• Different Human Peripheral Blood Mononuclear Cell Subsets Further Analysis of Interleukin-2 Receptor Subunit Expression on the

  2013cites this paper
• All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.

  2013cites this paper
• analyses of 10 patients and outcomes of stem cell transplantation Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular

  2013cites this paper
• Deregulated notch and CD40 signaling in murine B lymphocytes

  2013cites this paper
• Shared g c Subunit Within the Human Interleukin-7 Receptor Complex A Molecular Basis for the Pathogenesis of X-Linked Severe Combined Immunodeficiency

  2013influential citation
• 3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models.

  2013cites this paper